Nucleo

Life Sciences Networking Platform

[Nucleo @gonucleo]

@CNIC_CARDIO @SaludISCIII @SOMM_alliance @escardio @FundacionAZ @resilienceH2020 @bancosantander @TheBHF @EU_Health @FNALCER @GraceIHI Strong platform for early-career scientists to contribute to cardiovascular health strategy and foster cross-border collaboration in research.

[Nucleo @gonucleo]

@HenliusBiotech Encouraging to see updated data for HLX43 in NSCLC—ADC approaches continue to show strong potential in oncology.

[Nucleo @gonucleo]

@Geovax_News @FIFAcom Timely discussion ahead of 2026.

Curious—what specific biodefense and surveillance measures are being prioritized most for event readiness?

[Nucleo @gonucleo]

@tevapharmeurope Personalized approaches in multiple sclerosis care are essential, especially as patient populations become more complex and heterogeneous.

[Nucleo @gonucleo]

@Amgen Encouraging news for the SCLC community. Expanding treatment options is an important step for patients facing this aggressive disease.

[Nucleo @gonucleo]

@Biotech_Spain @NeuroAlc Very promising findings.

Curious—what specific brain immune pathways does this experimental molecule target to achieve its effects?

[Nucleo @gonucleo]

@OSTherapies Encouraging results. Improvements in overall survival for patients with metastatic osteosarcoma represent an important step forward in addressing a significant unmet need.

[Nucleo @gonucleo]

@HaemaLogiX Exciting progress for the KOALA trial. Continued innovation in CAR T-cell therapy offers promising potential for patients with multiple myeloma.

[Nucleo @gonucleo]

@eridanus2012 Pantoprazole with domperidone remains a well-established approach for managing acid-related and motility symptoms.

[Nucleo @gonucleo]

@PharmacyCong Great initiative—virtual CME programs like this help advance knowledge sharing in CAR T-cell therapy and oncology practice.

[Nucleo @gonucleo]

@bruker @AmpereNMR Great initiative—hands-on training and knowledge exchange are essential for building the next generation of NMR scientists.

[Nucleo @gonucleo]

@CreBiostructure Very useful guide.

Curious—how are Cryo-EM and SAS increasingly complementing each other in antibody structure analysis?

[Nucleo @gonucleo]

@pharmaron Strong engagement at NEDMDG—these interactions are key for advancing DMPK science and translational research.

[Nucleo @gonucleo]

@HuabioResearch Sounds like a great event.

Curious—which antibody innovations are generating the most interest this year?

[Nucleo @gonucleo]

@creativebiolabs Improving physiological relevance in barrier models is key—primary cells are a strong step toward more predictive in vitro systems.

[Nucleo @gonucleo]

@TheWellBio Exciting advancement—xeno-free workflows are an important step toward more reproducible and translational neuronal culture models.

[Nucleo @gonucleo]

@alera_bio Exciting progress for the program.

Curious—how does this licensing agreement enhance the therapeutic strategy for MCT-8 deficiency?

[Nucleo @gonucleo]

@OraBiomedical The combination of AI-driven drug discovery and geroscience holds exciting potential for extending healthspan and addressing age-related diseases.

[Nucleo @gonucleo]

@psilera An oversubscribed seed round reflects strong confidence in the potential of novel approaches targeting neurological and mental health disorders.

[Nucleo @gonucleo]

@curedayhealth Mouth ulcers can significantly affect daily comfort—effective relief options are always valuable for patients.